IL-15/IL-15Rα intracellular trafficking in human melanoma cells and signal transduction through the IL-15Rα

被引:63
作者
Pereno, R
Giron-Michel, J
Gaggero, A
Gazes, E
Meazza, R
Monetti, M
Monaco, E
Mishal, Z
Jasmin, C
Indiveri, F
Ferrini, S
Azzarone, B [1 ]
机构
[1] Hop Paul Brousse, INSERM, U506, F-94807 Villejuif, France
[2] Ist Nazl Ric Canc, I-16132 Genoa, Italy
[3] DIMI, Fac Med, I-16132 Genoa, Italy
[4] DOCS, Fac Med, F-94800 Villejuif, France
[5] Lab Cytometrie, CNRS, UPS 47, F-94800 Villejuif, France
[6] Hop Paul Brousse, INSERM, U268, F-94807 Villejuif, France
关键词
IL-15; IL-15R alpha; secretion pattern; NF-kappa B; melanoma progression;
D O I
10.1038/sj.onc.1203873
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
There are two IL-15 isoforms and eight isoforms for the IL-15R alpha chain whose biological role is poorly understood. Here, we have analysed the intracellular trafficking of IL-15 and IL-15R alpha and tried to shed some light on their function(s), In IL-15/GFP CHO transfectants both IL-15 isoforms show nuclear localization. Two melanoma cell lines (MELP and MELREO) spontaneously expressing the IL-15 isoforms, display different intracellular trafficking of the IL-15/IL-15R alpha complex, In MELP cells only IL-15R alpha is detected inside the nucleus, whereas IL-15 and IL-15R alpha assemble at the cell surface and are internalized, Moreover, the transducing molecule TRAF2 co-immunoprecipitates with IL-15R alpha and may be deflected to TNFRI using anti-IL-15 blocking mAbs and TNF-alpha, By contrast, MELREO cells display IL-15R alpha and IL-15 nuclear localization but only a partial co-localization of these molecules on the cell surface. In these cells, TRAF2 is strongly associated with IL-15R alpha and cannot be deflected by any treatment, Since TRAF2 activates the transcription factor NF-kappaB, IL-15 through IL-15R alpha, could have a role in the control of this pathway. Indeed, anti-IL-15 MaB inhibit the constitutive nuclear localization of NF kappaB and the phosphorylation of its inhibitor I kappa -B alpha, Thus, IL-15R alpha controls NF-KB activation, however differences in the intracellular trafficking of the IL-15 and/or IL-15R alpha suggest a different biological role for this complex in MELP versus MELREO cells.
引用
收藏
页码:5153 / 5162
页数:10
相关论文
共 22 条
[1]  
Alleva DG, 1997, J IMMUNOL, V159, P2941
[2]  
ANDERSON DM, 1995, J BIOL CHEM, V270, P29862
[3]  
Baker SJ, 1996, ONCOGENE, V12, P1
[4]   The NF-kappa B and I kappa B proteins: New discoveries and insights [J].
Baldwin, AS .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :649-683
[5]   Interleukin (IL) 15/IL-T production by the adult T-cell leukemia cell line HuT-102 is associated with a human T-cell lymphotrophic virus type I R region/IL-15 fusion message that lacks many upstream AUGs that normally attenuate IL-15 mRNA translation [J].
Bamford, RN ;
Battiata, AP ;
Burton, JD ;
Sharma, H ;
Waldmann, TA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (07) :2897-2902
[6]   IL-15 is produced by a subset of human melanomas, and is involved in the regulation of markers of melanoma progression through juxtacrine loops [J].
Barzegar, C ;
Meazza, R ;
Pereno, R ;
Pottin-Clemenceau, C ;
Scudeletti, M ;
Brouty-Boyé, D ;
Doucet, C ;
Taoufik, Y ;
Ritz, J ;
Musselli, C ;
Mishal, Z ;
Jasmin, C ;
Indiveri, F ;
Ferrini, S ;
Azzarone, B .
ONCOGENE, 1998, 16 (19) :2503-2512
[7]   RETRACTED: Death deflected:: IL-15 inhibits TNF-α-mediated apoptosis in fibroblasts by TRAF2 recruitment to the IL-15Rα chain (Retracted Article. See vol 25, pg 1118, 2011) [J].
Bulfone-Paus, S ;
Bulanova, E ;
Pohl, T ;
Budagian, V ;
Dürkop, H ;
Rückert, R ;
Kunzendorf, U ;
Paus, R ;
Krause, H .
FASEB JOURNAL, 1999, 13 (12) :1575-1585
[8]   Natural splicing of exon 2 of human interleukin-15 receptor α-chain mRNA results in a shortened form with a distinct pattern of expression [J].
Dubois, S ;
Magrangeas, F ;
Lehours, P ;
Raher, S ;
Bernard, J ;
Boisteau, O ;
Leroy, S ;
Minvielle, S ;
Godard, A ;
Jacques, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (38) :26978-26984
[9]  
Duffey DC, 1999, CANCER RES, V59, P3468
[10]  
Gaggero A, 1999, EUR J IMMUNOL, V29, P1265, DOI 10.1002/(SICI)1521-4141(199904)29:04<1265::AID-IMMU1265>3.0.CO